EROXON
A topical gel developed by Futura Medical of the UK (development code MED3000). It contains no drug substance, is classified as a medical device, and was authorised by the US FDA via the De Novo pathway.
- Product type
- Topical gel (medical device)
- Ingredients
- Non-medicated hydroalcoholic gel (alcohol, purified water, glycerin, propylene glycol, carbomer)
- Line-up / Units
- Eroxon Stimgel
- Form
- Topical gel
- Manufacturer
- Futura Medical plc
- Country of origin
- United Kingdom
Key points
- Drug-free medical device
- US FDA De Novo authorisation (2023)
Contact us for pricing and terms